This week, I wrote about a new proposed definition for ultra-processed foods, which prompted excellent follow-up questions from readers. Many wanted to better understand why these products are ...
This Pew Research Center analysis focuses on how Black Americans define and experience family – that is, who is included in their family networks and how they provide support to one another. Pew ...
Diet‑related diseases such as type 2 diabetes, obesity and hypertension, particularly those affecting children, remain ...
A practitioner's breakdown of AEO, GEO, and AIO. Learn where these terms originated, how they differ from traditional SEO, and how B2B companies use them to generate leads and grow revenue in 2026.
At least according to shadow treasurer Tim Wilson, who recently put forward the idea that small and family businesses will be ...
Montana Democrats gathered in the Motherlode Theater in Butte on Tuesday night for the first debate among the party’s four ...
WebFX reports that AI optimization is crucial for businesses, focusing on getting cited by AI platforms like ChatGPT and ...
Readers asked their biggest questions about the war with Iran. Our journalists break it down.
One might have thought the campus chaos that followed Oct. 7, 2023, would force a moment of academic sobriety. After the massacre in Israel, the country watched elite universities descend into moral ...
WISN 12 News on MSN
A surprising percentage of produce from the nation's largest supplier contains 'forever' pesticides
Nearly 40% of nonorganic fruits and vegetables grown in California contain traces of pesticides that are also PFAS, or "forever chemicals," according to a new investigation. California supplies nearly ...
3don MSN
Nearly 40% of California nonorganic produce has PFAS 'forever chemicals,' investigation shows
Nearly 40% of nonorganic fruits and vegetables grown in California contain traces of pesticides that are also PFAS, or "forever chemicals," according to a new investigation.
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results